Treg Cells for AGVHD in Non-myeloablative UCB Transplant

NCT02118311 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Changing study design. Will replace with a different protocol.

Conditions

Hematologic Malignancies

Interventions

BIOLOGICAL: T Regulatory cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]
[object Object]